The Campbell’s Company has rejected claims that it uses 3D-printed, lab-grown, or otherwise artificial chicken in its soups, calling the allegations “patently absurd” and reiterating that all of its chicken comes from USDA-approved U.S. suppliers.
The company, formerly known as the Campbell Soup Company, issued a statement on Nov. 25 after the emergence of an audio recording in which a senior IT executive appeared to disparage the company’s products and customers.
The audio allegedly captures Martin Bally, Campbell’s vice president of information technology, making a series of insulting remarks about Campbell’s food, customers, and workforce, including mocking the company’s soup as “highly process[ed] food” for “poor people,” along with suggestions that the company use “bioengineered meat.”
“Even in a can of soup, I look at it, and look at bioengineered meat,” the person in the recording says. “I don’t want to eat a [expletive] piece of chicken that came from a 3D printer, do you?”
The Epoch Times has been unable to verify the authenticity of the recording.
Garza alleged in his complaint that he was fired in January after notifying his manager that he wanted to report the comments to human resources, and is seeking monetary damages.
“If the comments heard on the audio recording were in fact made by Mr. Bally, they are unacceptable,” the company said. “Such language does not reflect our values and the culture of our company. We do not tolerate that kind of language under any circumstances.”
Campbell’s also rebutted claims that it uses artificial, engineered, or 3D-printed chicken in its soups.
“The comments heard on the recording about our food are not only inaccurate—they are patently absurd,” Campbell’s said. “The chicken meat in our soups comes from long-trusted, USDA approved U.S. suppliers and meets our high quality standards. All our soups are made with No Antibiotics Ever chicken meat. Any claims to the contrary are completely false.”
The Epoch Times reached out to Garza’s attorney, Zachary Runyan, for comment, but did not receive a response by publication time.







